Stanford researchers will discuss their agentic 'scientists' that are on course to reshape drug discovery at VB Transform 2026

Drug discovery is notoriously inefficient. Pharmaceutical projects span years, moving from one specialized human team to the next through disconnected workflows that result in knowledge loss during each handoff. A shocking 90% to 95% of drug discovery projects reportedly fail — one of the highest failure rates of any industry.